Larry Biegelsen
Stock Analyst at Wells Fargo
(3.81)
# 673
Out of 4,876 analysts
309
Total ratings
53.54%
Success rate
6.64%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Maintains: Overweight | $118 → $93 | $69.69 | +33.45% | 17 | May 30, 2025 | |
| MMSI Merit Medical Systems | Maintains: Overweight | $106 → $108 | $92.80 | +16.38% | 9 | May 21, 2025 | |
| RXST RxSight | Upgrades: Overweight | $17 → $25 | $13.23 | +88.96% | 13 | May 19, 2025 | |
| HYPR Hyperfine | Maintains: Equal-Weight | $1.29 → $0.68 | $0.73 | -7.00% | 5 | May 14, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $113 → $98 | $91.74 | +6.82% | 10 | May 6, 2025 | |
| INSP Inspire Medical Systems | Maintains: Equal-Weight | $195 → $174 | $129.71 | +34.15% | 12 | May 6, 2025 | |
| TFX Teleflex | Maintains: Equal-Weight | $146 → $137 | $119.58 | +14.57% | 5 | May 2, 2025 | |
| BAX Baxter International | Maintains: Equal-Weight | $36 → $33 | $30.50 | +8.20% | 16 | May 2, 2025 | |
| BLCO Bausch + Lomb | Maintains: Equal-Weight | $15 → $12 | $12.07 | -0.58% | 6 | May 1, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Overweight | $103 → $89 | $74.86 | +18.89% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $22 → $20 | $19.09 | +4.79% | 9 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $160 → $86 | $101.27 | -15.07% | 14 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $305 → $315 | $253.58 | +24.22% | 18 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $28 | $17.90 | +56.42% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $118 | $104.58 | +12.83% | 13 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $17 | $10.94 | +55.39% | 1 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $427 → $435 | $390.40 | +11.42% | 15 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $630 → $687 | $534.19 | +28.61% | 19 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $166 → $152 | $152.01 | -0.01% | 13 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $10 → $8 | $2.59 | +208.88% | 6 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $90 → $94 | $85.04 | +10.54% | 9 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $106 → $98 | $86.18 | +13.72% | 17 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $90 → $80 | $77.15 | +3.69% | 15 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $105 | $87.17 | +20.45% | 8 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $42 → $40 | $17.10 | +133.92% | 17 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $40 → $49 | $12.21 | +301.31% | 2 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $136 | $133.67 | +1.74% | 21 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $58.82 | +19.01% | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $270 | $169.97 | +58.85% | 5 | Apr 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $80.74 | - | 2 | Nov 2, 2017 |
The Cooper Companies
May 30, 2025
Maintains: Overweight
Price Target: $118 → $93
Current: $69.69
Upside: +33.45%
Merit Medical Systems
May 21, 2025
Maintains: Overweight
Price Target: $106 → $108
Current: $92.80
Upside: +16.38%
RxSight
May 19, 2025
Upgrades: Overweight
Price Target: $17 → $25
Current: $13.23
Upside: +88.96%
Hyperfine
May 14, 2025
Maintains: Equal-Weight
Price Target: $1.29 → $0.68
Current: $0.73
Upside: -7.00%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $113 → $98
Current: $91.74
Upside: +6.82%
Inspire Medical Systems
May 6, 2025
Maintains: Equal-Weight
Price Target: $195 → $174
Current: $129.71
Upside: +34.15%
Teleflex
May 2, 2025
Maintains: Equal-Weight
Price Target: $146 → $137
Current: $119.58
Upside: +14.57%
Baxter International
May 2, 2025
Maintains: Equal-Weight
Price Target: $36 → $33
Current: $30.50
Upside: +8.20%
Bausch + Lomb
May 1, 2025
Maintains: Equal-Weight
Price Target: $15 → $12
Current: $12.07
Upside: -0.58%
GE HealthCare Technologies
May 1, 2025
Maintains: Overweight
Price Target: $103 → $89
Current: $74.86
Upside: +18.89%
May 1, 2025
Maintains: Equal-Weight
Price Target: $22 → $20
Current: $19.09
Upside: +4.79%
May 1, 2025
Downgrades: Equal-Weight
Price Target: $160 → $86
Current: $101.27
Upside: -15.07%
Apr 24, 2025
Maintains: Overweight
Price Target: $305 → $315
Current: $253.58
Upside: +24.22%
Mar 31, 2025
Initiates: Overweight
Price Target: $28
Current: $17.90
Upside: +56.42%
Feb 6, 2025
Maintains: Overweight
Price Target: $100 → $118
Current: $104.58
Upside: +12.83%
Jan 30, 2025
Maintains: Overweight
Price Target: $13 → $17
Current: $10.94
Upside: +55.39%
Jan 29, 2025
Maintains: Overweight
Price Target: $427 → $435
Current: $390.40
Upside: +11.42%
Jan 24, 2025
Maintains: Overweight
Price Target: $630 → $687
Current: $534.19
Upside: +28.61%
Jan 23, 2025
Maintains: Equal-Weight
Price Target: $166 → $152
Current: $152.01
Upside: -0.01%
Dec 11, 2024
Maintains: Equal-Weight
Price Target: $10 → $8
Current: $2.59
Upside: +208.88%
Dec 11, 2024
Maintains: Overweight
Price Target: $90 → $94
Current: $85.04
Upside: +10.54%
Nov 20, 2024
Maintains: Overweight
Price Target: $106 → $98
Current: $86.18
Upside: +13.72%
Sep 9, 2024
Maintains: Overweight
Price Target: $90 → $80
Current: $77.15
Upside: +3.69%
Aug 22, 2024
Maintains: Overweight
Price Target: $94 → $105
Current: $87.17
Upside: +20.45%
Jul 26, 2024
Maintains: Overweight
Price Target: $42 → $40
Current: $17.10
Upside: +133.92%
Dec 5, 2023
Upgrades: Overweight
Price Target: $40 → $49
Current: $12.21
Upside: +301.31%
Apr 5, 2023
Maintains: Overweight
Price Target: $140 → $136
Current: $133.67
Upside: +1.74%
May 11, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $58.82
Upside: +19.01%
Apr 8, 2020
Maintains: Overweight
Price Target: $279 → $270
Current: $169.97
Upside: +58.85%
Nov 2, 2017
Upgrades: Outperform
Price Target: n/a
Current: $80.74
Upside: -